Study on Fatigue in Colorectal Cancer Survivors, a Lifestyle Intervention

NCT05390398 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 161

Last updated 2025-03-28

No results posted yet for this study

Summary

The SoFiT study is a randomized controlled trial examining the effects of a behaviour change guided lifestyle intervention on increasing adherence to the World Cancer Research Fund cancer prevention guidelines, compared to the wait-list usual care group, on diminishing cancer-related fatigue in colorectal cancer survivors.

Conditions

Interventions

BEHAVIORAL

Behaviour change guided lifestyle intervention

Participants in the intervention group receive personalized coaching from a lifestyle coach on adhering to the World Cancer Research Fund cancer prevention guidelines. The lifestyle coach is specialized in behaviour change techniques and uses these as the core of the lifestyle coaching. For each participant behavioural determinants will be assessed and targeted with specific applicable behaviour change techniques.

Sponsors & Collaborators

  • World Cancer Research Fund International

    collaborator OTHER
  • Gelderse Vallei Hospital

    collaborator OTHER
  • Flevoziekenhuis

    collaborator OTHER
  • Slingeland Hospital

    collaborator OTHER
  • Rijnstate Hospital

    collaborator OTHER
  • Het Prospectief Landelijk CRC cohort (PLCRC)

    collaborator UNKNOWN
  • Deventer Ziekenhuis

    collaborator OTHER
  • Wageningen University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-18
Primary Completion
2024-06-30
Completion
2024-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05390398 on ClinicalTrials.gov